<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Should Lilly Buy Amylin Pharmaceuticals?</title>
	<atom:link href="http://www.pharmalot.com/2008/08/should-lilly-buy-amylin-pharmaceuticals/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/08/should-lilly-buy-amylin-pharmaceuticals/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Mon, 22 Mar 2010 05:16:07 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Gretchen</title>
		<link>http://www.pharmalot.com/2008/08/should-lilly-buy-amylin-pharmaceuticals/#comment-368396</link>
		<dc:creator>Gretchen</dc:creator>
		<pubDate>Fri, 01 Aug 2008 16:25:34 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14928#comment-368396</guid>
		<description>I would actually suggest that Amylin is a really a one-platform story.  They're basically using the one technology they have to develop additional drugs for other therapeutic areas.  Interview with their head of R&#38;D here:
http://envisagemag.com/mediacast/a-common-path

Nonetheless, I can't see why Lilly would want to take them over.</description>
		<content:encoded><![CDATA[<p>I would actually suggest that Amylin is a really a one-platform story.  They&#8217;re basically using the one technology they have to develop additional drugs for other therapeutic areas.  Interview with their head of R&amp;D here:<br />
<a href="http://envisagemag.com/mediacast/a-common-path" rel="nofollow">http://envisagemag.com/mediacast/a-common-path</a></p>
<p>Nonetheless, I can&#8217;t see why Lilly would want to take them over.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Scott</title>
		<link>http://www.pharmalot.com/2008/08/should-lilly-buy-amylin-pharmaceuticals/#comment-368394</link>
		<dc:creator>Scott</dc:creator>
		<pubDate>Fri, 01 Aug 2008 15:56:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14928#comment-368394</guid>
		<description>Carl Icahn already owns a big share of Amylin ... I suspect he wants to ensure he gets a rich premium on those shares!</description>
		<content:encoded><![CDATA[<p>Carl Icahn already owns a big share of Amylin &#8230; I suspect he wants to ensure he gets a rich premium on those shares!</p>
]]></content:encoded>
	</item>
</channel>
</rss>
